1. US FDA warns of possible EpiPen auto-injector errors/malfunction

   News item 04 April 2020 Pages: 1 - 1

2. Global operation targets rise in counterfeit COVID-related medical items

   News item 04 April 2020 Pages: 2 - 2

3. Regulatory agencies issue advice on use of NSAIDs for COVID-19

   News item 04 April 2020 Pages: 3 - 3

4. ADRs of afatinib, erlotinib, gefitinib, osimertinib reviewed

   News item 04 April 2020 Pages: 4 - 4

5. Antipsychotics associated with osteoporosis?

   Clinical study 04 April 2020 Pages: 5 - 5

6. Cardiac toxicity: ICI monotherapy vs combination therapy

   Clinical study 04 April 2020 Pages: 6 - 6

7. Changes in analgesic use after rescheduling of codeine in Australia

   Clinical study 04 April 2020 Pages: 7 - 7

8. Chronic inflammatory diseases: hypertension with oral glucocorticoids

   Clinical study 04 April 2020 Pages: 8 - 8

9. Coverage of DHPCs by the media in the Netherlands

   Clinical study 04 April 2020 Pages: 9 - 9

10. Levodopa/carbidopa/entacapone in early Parkinson's disease

    Unknown 04 April 2020 Pages: 10 - 10

11. Risk of cardiac events with GnRH agonists but not antagonists

    Clinical study 04 April 2020 Pages: 11 - 11

12. Typhoid conjugate vaccine adverse events in Hyderabad

    Clinical study 04 April 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 April 2020 Pages: 13 - 13

14. Abacavir/dolutegravir/lamivudine

    Case report 04 April 2020 Pages: 14 - 14

15. Acetazolamide

    Case report 04 April 2020 Pages: 15 - 15

16. Acetazolamide/topiramate

    Case report 04 April 2020 Pages: 16 - 16

17. Aciclovir/epinephrine/methylprednisolone

    Case report 04 April 2020 Pages: 17 - 17

18. Adalimumab

    Case report 04 April 2020 Pages: 18 - 18

19. Adalimumab

    Case report 04 April 2020 Pages: 19 - 19

20. Adalimumab

    Case report 04 April 2020 Pages: 20 - 20

21. Aflibercept

    Case report 04 April 2020 Pages: 21 - 21

22. Alectinib/crizotinib/lorlatinib

    Case report 04 April 2020 Pages: 22 - 22

23. Alteplase

    Case report 04 April 2020 Pages: 23 - 23

24. Alteplase/aspirin

    Case report 04 April 2020 Pages: 24 - 24

25. Amantadine withdrawal

    Case report 04 April 2020 Pages: 25 - 25

26. Amikacin/linezolid/tigecycline

    Case report 04 April 2020 Pages: 26 - 26

27. Amoxicillin/clavulanic acid/epinephrine

    Case report 04 April 2020 Pages: 27 - 27

28. Ampicillin

    Case report 04 April 2020 Pages: 28 - 28

29. Anti-infectives

    Case report 04 April 2020 Pages: 29 - 29

30. Antiasthmatics/prednisolone

    Case report 04 April 2020 Pages: 30 - 30

31. Antihypotensives

    Case report 04 April 2020 Pages: 31 - 31

32. Antineoplastics

    Case report 04 April 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 04 April 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 04 April 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 04 April 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 04 April 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 04 April 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 04 April 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 04 April 2020 Pages: 39 - 39

40. Antineoplastics

    Case report 04 April 2020 Pages: 40 - 40

41. Antineoplastics

    Case report 04 April 2020 Pages: 41 - 41

42. Antineoplastics

    Case report 04 April 2020 Pages: 42 - 42

43. Antineoplastics/folinic acid

    Case report 04 April 2020 Pages: 43 - 43

44. Antineoplastics/pirarubicin

    Case report 04 April 2020 Pages: 44 - 44

45. Antiretrovirals/penicillamine/trientine

    Case report 04 April 2020 Pages: 45 - 45

46. Antituberculars

    Case report 04 April 2020 Pages: 46 - 46

47. Antituberculars

    Case report 04 April 2020 Pages: 47 - 47

48. Antituberculars

    Case report 04 April 2020 Pages: 48 - 48

49. Antituberculars/antibacterials/prednisolone

    Case report 04 April 2020 Pages: 49 - 49

50. Apixaban

    Case report 04 April 2020 Pages: 50 - 50